✦ LIBER ✦

Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis

✍ Scribed by H. P. Hoensch; K. Balzer; P. Dylewizc; W. Kirch; H. Goebell; E. E. Ohnhaus

Publisher: Springer
Year: 1985
Tongue: English
Weight: 354 KB
Volume: 28
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00544371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of ursodeoxycholic acid on bile a

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis

✍ Dr. Ashok K. Batta; Gerald Salen; Renu Arora; Sarah Shefer; G. Stephen Tint; Joh 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

We have compared the effect of ursodeoxycholic acid with placebo on the clinical state, blood liver chemistries and serum and urinary bile acids in four patients with primary biliary cirrhosis. All parameters were evaluated monthly, and bile acid composition was measured by capillary gas-liquid chro

Serum bile acids in primary biliary cirr

Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy

✍ Renée E. Poupon; Yves Chrétien; Raoul Poupon; Gustav Paumgartner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Ursodeoxycholic acid–induced changes of

Ursodeoxycholic acid–induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

✍ Adolf Stiehl; Gerda Rudolph; Richard Raedsch; Bernd Moller; Ulrich Hopf; Erich L 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

Ursodeoxycholic acid treatment of patients with primary biliary cirrhosis may lead to relief of pruritus and improvement of biochemical liver tests. The changes in serum and urinary bile acids induced by ursodeoxycholic acid treatment were studied. After 29 patients with primary biliary cirrhosis we

Effects of systemic prostaglandin e on h

Effects of systemic prostaglandin e on hepatic amino acid-nitrogen metabolism in patients with cirrhosis

✍ Andrea Fabbri; Giampaolo Bianchi; Mara Brizi; Elisabetta Bugianesi; Donatella Ma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Prostaglandins of the E (PGE) series have long been considered ''catabolic'' hormones, but recent data suggest that they may be secreted in critically ill patients to counteract stress hormones, stimulating protein synthesis. Their use is under scrutiny to improve hepatic microcirculation and as cyt

Effect of pretransplantation ursodeoxych

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis

✍ Heathcote, E. Jenny ;Stone, Julie ;Cauch-Dudek, Karen ;Poupon, Raoul ;Chazouille 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 42 KB 👁 1 views

As ursodeoxycholic acid (UDCA) delays the need for transplantation, this could result in patients with more comorbid disease, therefore more likely to have a worse outcome posttransplantation. The aim of this study is to compare posttransplantation outcome in patients who received UDCA versus placeb

Differences in the metabolism and dispos

Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis

✍ Pietro Invernizzi; Kenneth D. Setchell; Andrea Crosignani; Pier Maria Battezzati 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

The clinical effectiveness of ursodeoxycholate in the treatment of liver disease may be limited by its poor absorption and extensive biotransformation. Because in vitro and in vivo studies suggest that the more hydrophilic bile acid tauroursodeoxycholate has greater beneficial effects than ursodeoxy